| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Eldred Kary is a Director at GALECTIN THERAPEUTICS INC. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $137K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 31, 2019 | GALT Galectin Therapeutics Inc | Director | Buy | 3,033 | $4.28 | $12,981.24 | +7.3% | |
| Sep 25, 2018 | GALT Galectin Therapeutics Inc | Director | Buy | 2,000 | $6.10 | $12,199.80 | +5.1% |